Antibiotic resistance in gonorrhea Antibiotic resistance in gonorrhea The Gonorrhea bacterium Neisseria gonorrhoeae has developed antibiotic resistance to many antibiotics. The bacteria was first identified in 1879, although some Biblical scholars believe that references to the disease can be found as early as Parshat Metzora of the Old Testament. In the 1940s effective treatment with penicillin became available, but by the 1970s resistant strains predominated. Resistance to penicillin has developed through two mechanisms: chromasomally mediated resistance (CMRNG) and penicillinase-mediated resistance (PPNG). CMRNG involves step wise mutation of penA, which codes for the penicillin-binding protein (PBP-2); mtr, which encodes an efflux pump that removes penicillin
Antibiotic use in livestock for not collecting enough information and data on antibiotic use in factory farms. From this, the GAO concluded that the FDA does not have enough information to create effective policy changes regarding antibiotic use. In response, the FDA insisted that more research was being conducted and voluntary efforts within the industry would solve the problem of antibiotic resistance. Few policies exist that limit antibiotic use on factory farms, and some proposed legislation in the US has failed to be adopted. In 2007, two federal bills (S. 549 and H.R. 962) aimed to phase out nontherapeutic antibiotics in U.S. food animal